Note this is a video recording of an online meeting conducted using the Zoom.us platform. Inevitably such recordings suffer a little in terms of their production values because of the internet connectivity and quality of webcams. Despite that, they allow us to provide additional valuable insights in to the MedComms business and we can involve a wider range of speakers who can participate from the comfort of their own desks, wherever in the world they are.

In this webinar, we are joined by team members from the AMICULUM agencies Seques and Comradis as they discuss working in the specialist fields of rare diseases (Comradis) and cell and gene therapies (Seques). The panel explain the importance of working in these areas, as well as the main challenges faced and how to overcome them. Our panellists are Isabelle Blomfield (Seques), Rachael Ducker (Comradis), Maggie Lai (Comradis) and Steve North (Seques). And we answer questions from the audience.

It should be of interest to anyone who is working in and around MedComms, or who is wanting to join the business.

Recorded 20 April 2022 as a MedComms Networking webinar. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

Isabelle’s LinkedIn page is at https://www.linkedin.com/in/isabelle-maria-blomfield/

Rachael’s LinkedIn page is at https://www.linkedin.com/in/rachael-ducker-097b4957/

Maggie’s LinkedIn page is at https://www.linkedin.com/in/maggie-lai-b9a67215/

Steve’s LinkedIn page is at https://www.linkedin.com/in/steve-north-8293444a/

Find out more about AMICULUM at http://www.amiculum.biz/

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =  = = = = = = = = = = = = = =

We are building a library of free webcasts and other video content for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new content.

[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at http://www.medcommsnetworking.com]